U.S. Food and Drug Administration

Dockets logo

FR Home ] Dockets Home ] [ FDA Home Page ]



Federal Register

Vol. 69 , No.

Thursday, September 23, 2004

Contents (TXT)  (PDF)

Documents and comments received by the Dockets Management Branch "MAY" be posted on the Internet. Please "DO NOT INCLUDE" personal identifying information, i.e. date of birth, social security number, medical information, etc., in your correspondence. Documents are on display for public inspection at the Dockets Management Branch,  5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.


NOTICES-FINAL GUIDANCES

Docket No. 2004D-0371, CDRH 200436.  Guidance for Industry and Food and Drug Administration Staff: Class II Special Controls Guidance Document: Serological Assays for the Detection of Beta-Glucan; Availability.  Pages  57034-57035 [FR Doc. 04-21317]  [TXT] [PDF] [PRE-PUB] Comments by September 23, 2005
The Guidance PDF Version
The Guidance Word Version

NOTICES

Docket No. 2004N-0408, CBER 200425.  Regulatory Site Visit Training Program.  Pages  57033-57034 [FR Doc. 04-21318]  [TXT] [PDF] [PRE-PUB] electronic requests for participation by October 25, 2004

FINAL RULES

Docket No. 2004N-0370, CDRH 200437.  Medical Devices; Immunology and Microbiology Devices; Classification of the Beta-Glucan Serological Assay.  Pages  56934-56936 [FR Doc. 04-21316]  [TXT] [PDF] [PRE-PUB] Effective October 25, 2004


Top ] FR Home ] Dockets Home ] [ FDA Home Page ]